Bristol Myers Squibb

Forecast & Rating29 analysts currently cover Bristol Myers Squibb, with about 34.5% giving a positive rating — meaning they expect the stock to rise. The average price target is $66.71, about 6.7% upside from the current price of $62.54. Price targets range from $40.00 to $82.00 — a wide spread, showing clear disagreement over just how much Bristol Myers Squibb can rise. Historically, about 27.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on Bristol Myers Squibb's outlook. Data as of Sep 15, 2026; for reference only and not investment advice.